Dr Florian Markowetz awarded a CRUK Future Leaders Prize

Dr Florian Markowetz was one of three researchers awarded a Cancer Research UK Future Leaders in Cancer Research Prize at an awards ceremony at the National Cancer Research Institute (NCRI) Cancer Conference.
This prize recognises scientists early in their career whose significant contribution to cancer research demonstrates their potential to become world-class leaders in their field.
Dr Florian Markowetz’s work is providing insights into how tumours interact with their environment. By studying the cancer’s genes in the context of the tissue around it, they are finding which signals indicate how a cancer will behave. You can find out more about his work here.
Sir Harpal Kumar, chief executive of Cancer Research UK, said: “I’m delighted to announce this year’s prize winners. These pioneering scientists are receiving awards for their extraordinary and wide-ranging contributions to cancer research. Although their work spans many different areas and types of cancer, they all share a determination to beat cancer for good. Through their pioneering work they open up new opportunities to detect and treat cancer which will help us save lives.”
Related News
See all news-
New clue discovered for why some cancer drugs fall short
11th July 2025
Hedgehog signalling plays a key role in controlling how immune cells migrate into tumours, a discovery that may explain why some cancer drugs have underperformed in clinical trials.
Read more -
Dr Jane Gray made guest of honour at Race for Life
3rd July 2025
The Cambridge Institute scientist, who is currently undergoing treatment for breast cancer, took part in this year’s race, inspiring thousands with her story of resilience and hope.
Read more -
Prof Sir Shankar Balasubramanian Awarded Prestigious Royal Society of Chemistry Prize
25th June 2025
Professor Sir Shankar Balasubramanian has received the Royal Society of Chemistry Khorana Prize, awarded for outstanding contributions through work at the chemistry and life science interface.
Read more